微创医疗(00853)今日盘中出现大跌,股价下跌5.01%,引发市场关注。据了解,这与知名投行摩根士丹利发布的一份研究报告有关。
摩根士丹利在报告中下调了微创医疗2027-2030年的每股盈利预期5-9%,原因是预计在持续的定价压力下,公司2027-2030年的增长和利润率将较为保守。与此同时,分析师还将评估微创医疗各业务部门时的估值折让率提高了1-2.5个百分点。
由于上述调整,摩根士丹利将微创医疗的目标股价从7.4港元下调至6.4港元,调低幅度达14%。尽管如此,该券商维持了对微创医疗"与大市同步"的投资评级。值得注意的是,摩根士丹利上调了对微创医疗2024和2025年每股盈利的预期,但下调了2026年的预期。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.